FENC - Fennec Pharmaceuticals Inc Stock Price, Fair Value and News

$4.49-0.05 (-1.10%)

Delayed as of 23 Oct 2024, 02:48 pm ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

FENC Price Action

Last 7 days

-2.4%

Last 30 days

-13.4%

Last 90 days

-30.9%

Trailing 12 Months

-33.2%

FENC RSI Chart

FENC Valuation

Market Cap

124.2M

Price/Earnings (Trailing)

-14.18

Price/Sales (Trailing)

2.54

Price/Free Cashflow

5.39

FENC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

FENC Fundamentals

FENC Revenue

Revenue (TTM)

48.9M

Rev. Growth (Yr)

566.71%

Rev. Growth (Qtr)

58.1%

FENC Earnings

Earnings (TTM)

-8.8M

Earnings Growth (Yr)

-2%

Earnings Growth (Qtr)

-143.26%

FENC Profitability

Return on Equity

645.62%

Return on Assets

-13.87%

Free Cashflow Yield

18.55%

FENC Investor Care

Shares Dilution (1Y)

3.00%

Diluted EPS (TTM)

0.05

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	45.0M	48.9M	0	0
2023	3.2M	6.5M	12.8M	21.3M
2022	0	161.0K	59.0K	1.5M
2021	0	0	230.0K	174.0K
2020	0	0	271.0K	287.0K
2019	355.0K	392.0K	361.0K	315.0K
2018	103.0K	171.0K	256.0K	348.0K
2017	11.0K	13.0K	26.0K	47.0K
2016	0	5.0K	7.0K	8.0K
2015	5.0K	3.0K	4.0K	3.0K
2014	0	2.0K	2.0K	2.0K
2013	20.5K	0	11.3K	2.0K
2012	44.5K	46.0K	30.0K	26.5K
2011	0	0	0	43.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

CEO	Mr. Rostislav Raykov
WEBSITE	fennecpharma.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	36

Fennec Pharmaceuticals Inc Frequently Asked Questions

What is the ticker symbol for Fennec Pharmaceuticals Inc? What does FENC stand for in stocks?

FENC is the stock ticker symbol of Fennec Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Fennec Pharmaceuticals Inc (FENC)?

As of Tue Oct 22 2024, market cap of Fennec Pharmaceuticals Inc is 124.23 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of FENC stock?

You can check FENC's fair value in chart for subscribers.

Is Fennec Pharmaceuticals Inc a good stock to buy?

The fair value guage provides a quick view whether FENC is over valued or under valued. Whether Fennec Pharmaceuticals Inc is cheap or expensive depends on the assumptions which impact Fennec Pharmaceuticals Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for FENC.

What is Fennec Pharmaceuticals Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Oct 22 2024, FENC's PE ratio (Price to Earnings) is -14.18 and Price to Sales (PS) ratio is 2.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. FENC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Fennec Pharmaceuticals Inc's stock?

In the past 10 years, Fennec Pharmaceuticals Inc has provided 0.191 (multiply by 100 for percentage) rate of return.